Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Anthrax: Exposure Management/Prophylaxis

CDC guidance on screening and evaluating patients after they have been exposed to anthrax and preventing anthrax after exposure can be found in the April 2008 issue of Emerging Infectious Diseases journal, available from http://wwwnc.cdc.gov/eid/article/14/4/07-0969.htm.

Overviews

Specific Drugs

  • Patient Information: Ciprofloxacin
    General information for patients prescribed ciprofloxacin for anthrax. Includes side effects & precautions.
    Jan 20, 2004

  • Emergency Use Authorization: Doxycycline
    Information about the U.S. Food and Drug Administration’s issuance of an Emergency Use Authorization (EUA) for distribution of doxycycline to people who may have been exposed to anthrax in an emergency event. 
    July 21, 2011

  • Patient Information: Doxycycline
    General information for patients prescribed doxycycline for anthrax. Includes side effects & precautions.
    Jan 20, 2004
  • Patient Information: Amoxicillin
    General information for patients prescribed amoxicillin for anthrax. Includes side effects & precautions.

Guidelines

Adverse Events

Historical Archives: 2001 Outbreak & Other Incidents

  • Page last reviewed: November 19, 2012
  • Page last updated: November 19, 2012
Contact Us:
Ready.gov - Prepare. Plan. Stay Informed.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #